Vivienne Raper

1 week ago | genengnews.com | Vivienne Raper

CAR T-cells attack cancer cell, 3D illustration. [Nemes Laszlo/Getty Images] Barcelona’s blood and tissue bank, Banc de Sang i Teixits, reports that it has developed a new system for the large-scale production of mesenchymal stromal cells (MSCs). The team says they’ve validated a stirred-tank bioreactor system they hope will help supply hospitals with cheaper treatments for conditions including myocardial infraction and spinal cord injury.

2 weeks ago | genengnews.com | Vivienne Raper

Credit: Adventtr/Getty Images A Danish company says they’ve found a way in helping to stop cells from “micro-evolving” during manufacturing to produce fewer monoclonal antibodies (mAbs). Enduro Genetics, which specializes in synthetic biology, says they’ve developed genetic plugins featuring biosensors and promoters that can detect and regulate mAb production levels in cells.

3 weeks ago | genengnews.com | Vivienne Raper

Scientists from the Massachusetts Institute of Technology (MIT) say they have developed a simpler process for messenger RNA (mRNA) purification based on continuous precipitation. According to Maria del Carme Pons Royo, PhD, a postdoctoral researcher at MIT, the process, already used at lab scale, could help make large-scale mRNA manufacturing more flexible and cost-efficient.

1 month ago | genengnews.com | Vivienne Raper

Home Topics Bioprocessing Benefits of Breaking Up Virus-Like Particles for Biomanufacturing Virus-like particles (VLPs) in green contain no viral genetic material. The genetic material in the virus (red) is RNA. [Design Cells/Getty Images] Virus-like particles (VLPs) in green contain no viral genetic material. The genetic material in the virus (red) is RNA.

1 month ago | genengnews.com | Vivienne Raper

Home Topics Bioprocessing Insourcing Cell-line Development Streamlines Antibody Biomanufacturing Credit: Reptile8488/Getty Images Credit: Reptile8488/Getty Images Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab, based in Denmark.